October 2026– date –

A 2022 study built a machine-learning model from routine tests in 154 patients with primary aldosteronism to predict unilateral versus bilateral disease, potentially helping decide who should undergo adrenal vein sampling.

A 2025 JCEM study sequenced 25 genes in 185 Japanese children with 46,XY differences of sex development (DSD) and found a monogenic cause in about 26%, more often when Müllerian structures were present or the external genitalia were female-typical.

A 2020 Molecular Cell study showed that feeding prompts adipose tissue macrophages to make IL-10 in response to both insulin and gut-derived LPS, suppressing hepatic glucose production — a mechanism impaired in obesity.

A 2026 study of 413 inpatients at Tokyo Medical University Hospital used a multistate model to show that patients with diabetes moved to ICU care or death faster, with the first 14 days being the critical window.

A 2021 study in Diabetes showed that MEK/ERK signaling in β-cells regulates both β-cell proliferation and mass and insulin exocytosis. We review findings in mice and human islets and their implications for therapy.

Our 2024 Thyroid study showed that all 12 disulfide bonds of thyroid peroxidase (TPO) are essential for its activity. We explain why blocking degradation does not restore activity and what this means for genetic diagnosis.

Our 2025 PLoS One study analyzed DPC data on about 10,000 inpatients from 38 hospitals in Chiba, Japan. People with diabetes had higher risks of in-hospital death, mechanical ventilation, ICU admission and dialysis. We also discuss how to interpret the results and their limits.

A September 2026 Nature study reported that semaglutide started late in life extended median lifespan by about 12% in female mice and improved several markers of aging, including hematopoietic stem cells and hippocampal neurogenesis. We discuss what “rejuvenation” means here and what remains unknown.